Compounds > tyrosine

tyrosine and Kidney Diseases

tyrosine has been researched along with Kidney Diseases in 71 studies

Research

Studies (71)

TimeframeStudies, this research(%)All Research%
pre-199017 (23.94)18.7374
1990's8 (11.27)18.2507
2000's24 (33.80)29.6817
2010's20 (28.17)24.3611
2020's2 (2.82)2.80

Authors

AuthorsStudies
Aasen, T; Abdul Moin, NI; Abdul Wafi, S; Aboukameel, A; Abu-Bakar, N; Acharya, A; Ackermans, L; Adaramoye, O; Adarsh, KV; Adeosun, WA; Ahmad, NH; Ahmadi, F; Akanni, O; Akbar, M; Akbulak, RO; Akev, N; Akkaya, Ö; Al-Rashed, S; AlAbbad, S; Alabi, O; Alappat, BJ; Alcalá, S; Alcoutlabi, M; Aleppo, G; Alexander Ross, JB; Alexander, JH; Alexander, R; Alias, A; Alimba, C; Alken, FA; Allan, R; Alpers, M; Alsbou, EM; Amarasiri, SS; An, T; Anastasiadis, F; Anastassiadou, M; Anderson, KC; Andronikos, P; Anheyer, D; Annapurna, K; Anorlu, RI; Anten, MM; Anthopoulos, TD; Araujo-Castillo, RV; Aravamudhan, S; Arawwawala, LDAM; Arulsamy, N; Arunamata, A; Asghar, A; Asiri, AM; Aslanidou, T; Astrakhantseva, IV; Astutik, E; Attanayake, AP; Atwater, BD; Audureau, E; Augusto, S; Bakare, A; Banach, M; Bandelier, P; Banerjee, S; Barral, M; Bascuñán, J; Bates, FS; Bauer, NJC; Bayrak, BB; Beck, RW; Beckervordersantforth, J; Beeri, R; Begum, R; Beldi-Ferchiou, A; Bellingham, G; Ben-Tal, N; Bendib, I; Bergenstal, RM; Berger, MF; Bernasconi, G; Berry, S; Beuvon, F; Bi, WJ; Bi, Z; Bianconi, V; Bibi, I; Blank, BR; Bliemeister, E; Bobkowski, W; Bode, AM; Booth, CM; Bose, U; Boyd, K; Brancato, A; Brenmoehl, J; Brogi, E; Bronzo, P; Brooks, T; Brown, D; Brown, DN; Bruce, D; Buan, MEM; Bueno-Hernández, F; Bugielski, B; Bulavaitė, A; Buscagan, TM; Buxton, R; Caffaro, MM; Cai, Q; Cai, X; Cai, Y; Calhoun, P; Callander, N; Cambier, S; Camparo, P; Canales-Vargas, EJ; Canham, K; Cantu, J; Cao, J; Cao, JW; Cao, P; Cao, T; Cao, X; Caravella, BA; Carcadea, E; Carè, J; Carmichael, P; Carrasco Cabrera, L; Carteaux, G; Carvalho, PDS; Casarez, E; Cazorla, M; Celestrin, CP; Chakraborty, NK; Chan, B; Chandarlapaty, S; Chandgude, AL; Chang, CC; Chang, JH; Chang, X; Chang, Y; Chankhanittha, T; Chantanis, S; Chapovetsky, A; Chavan, S; Chen, B; Chen, D; Chen, F; Chen, G; Chen, H; Chen, J; Chen, K; Chen, KJ; Chen, KP; Chen, L; Chen, MA; Chen, Q; Chen, S; Chen, W; Chen, WF; Chen, X; Chen, Y; Cheng, D; Cheng, J; Cheng, Q; Cheon, GJ; Chiu, SC; Cho, CH; Cho, J; Choi, H; Choi, JS; Choi, YH; Christie, P; Chu, CH; Chu, Y; Chung, DH; Chung, F; Cline, JP; Cohen, A; Cohen, AD; Cohen, NJ; Comen, E; Compter, I; Cong, J; Cong, Z; Cooper, A; Cornud, F; Costa, C; Costa, S; Covey, A; Cowan, AM; Cramer, H; Cruz-Rivera, C; Cui, J; Cui, M; Cui, Y; Cui, YH; Culquichicón, C; Cushman, T; D'Auria, SJ; da Silva, J; Dalgediene, I; Danenberg, HD; Das, S; Dasgupta, K; Daubit, IM; de Oliveira, PD; de Prost, N; De Ruysscher, D; Dearman, K; Decato, D; Delfau-Larue, MH; Deng, L; Dhakate, SR; Dharuman, V; Di Costanzo, N; Dickler, MN; Dinehart, EE; Ding, D; Dinh, TK; Divya, KP; Djifack Tadongfack, T; Do, T; Domínguez-Roldan, R; Domínguez-Zambrano, E; Dömling, A; Donato, MD; Dong, JH; Dong, W; Dong, X; Dong, XR; Dong, Y; Dong, Z; Downs, M; Drutskaya, MS; Du, B; Du, F; Du, H; Du, L; Du, X; Duan, Z; Duangthip, D; Dunstand-Guzmán, E; Duong, F; Eckert, DJ; Edelhäuser, BAH; Eekers, DBP; Efendi, F; Efraimidis, P; Ehrenberg, H; Ehsanbakhsh, Z; Eickholt, C; Eksterowicz, J; El Mobadder, M; El-Araby, IE; El-Magd, MA; El-Tarabany, MS; Elgorban, AM; Engelmann, D; English, KL; Esfandiari, H; Eslami, B; Espinosa-Cuevas, A; Eswara, S; Faber, E; Fan, XH; Fan, Y; Fang, J; Fang, Z; Fantin, VR; Fei, P; Feng, G; Feng, H; Feng, J; Feng, X; Feng, XJ; Fennell, TR; Fernández-Moreira, V; Ferraz, ABF; Ferreras, KN; Flores, K; Flores-Pérez, I; Flox, C; Fluharty, FL; Fokouong Tchoffo, E; Folefack, GO; Foroutan, T; Fort, D; Fourati, S; Fousas, S; Frapard, T; Freguia, S; Friedman, DJ; Friedman, LS; Fu, D; Fu, Q; Fu, Y; Fujinami, S; Furihata, K; Gal, RL; Gan, H; Gao, C; Gao, F; Gao, R; Gao, SS; Gao, W; Gao, XC; Gao, Y; Gao, Z; Garozi, L; Ge, J; Georgiopoulos, A; Gerakiou, K; Ghazimirsaeed, SM; Ghazimirsaeed, ST; Gimeno, MC; Gjestad, R; Glurich, I; Goetchius, E; Goland, S; Goldstein, S; Gonçalves, CM; Gonçalves, H; Gong, Q; Gonzalez, D; Goplen, FK; Gorshkova, EN; Gotsman, I; Govindasamy, V; Granger, CB; Greco, L; Grigoriadou-Skouta, E; Grigoropoulos, P; Grivicich, I; Gromov, NV; Gruber, S; Grytczuk, M; Grzech-Leśniak, K; Gu, L; Gu, S; Gu, Z; Guadagnini, D; Guan, H; Guilliams, M; Guo, J; Guo, L; Gupta, A; Gupta, SK; Gurzu, S; Gutleb, AC; Haban, A; Hablitz, JJ; Hadisuyatmana, S; Hahn, S; Haiges, R; Hallal-Calleros, C; Hamed, M; Hammad, N; Hammer, N; Han, C; Hao, Y; Harnett, J; Has, EMM; Hassanpour, K; Hatzopoulos, D; Hawaldar, R; He, X; He, Y; He, YY; He, Z; Heberman, D; Heckl, D; Hegde, H; Henson, MA; Hernández-Velázquez, VM; Herrera, E; Hijazi, Z; Hirayama, K; Hirth, JM; Hoeben, A; Hohnloser, SH; Hong, M; Hood, K; Hoplock, LB; Hopman, WM; Horlbogen, LM; Hossein Rashidi, B; Hou, G; Hou, H; Hou, J; Hou, Y; Hu, J; Hu, W; Hu, X; Hua, W; Huang, G; Huang, H; Huang, J; Huang, T; Huang, W; Huang, Y; Huang, YD; Huang, Z; Hudis, CA; Hue, S; Huo, J; Hussain, M; Hvas, AM; Ichii, T; Ide Zeuna, J; Ilyas, S; Inoue, T; Iranzo, A; Irfan, M; Iwasa, Y; Iwashita, Y; Izgorodina, EI; J R, A; Jaber, WA; Jaborek, JR; Jacobus, SJ; Jadeja, SD; Jafarabadi, M; Jalan, D; Jamil, MI; Jarrah, S; Jarvis, D; Jayatilaka, KAPW; Jemal-Turki, A; Jeon, YK; Jeong, N; Jeong, SH; Jeong, SY; Jermy, M; Jhaveri, K; Ji, H; Ji, K; Ji, RY; Jiang, F; Jiang, J; Jiang, X; Jiang, Y; Jiao, Q; Jilani, K; Jiménez-Guerrero, P; Jin, L; Jo, YH; Johnson, JG; Johnson, ML; Jones, WS; Jose, S; Jularic, M; Jung, I; Jung, YJ; Jungen, C; Junttila, MR; Kache, S; Kahanovitch, U; Kalantzi, KI; Kallio, T; Kamnoedboon, P; Kang, CH; Kang, H; Kang, J; Kang, KW; Kapoor, P; Karmakar, D; Kartalis, A; Kauranen, P; Kazocina, A; Keikha, F; Keltai, M; Kershaw, SV; Kettani, M; Khalvati, S; Khandhar, S; Khosla, N; Kiely, CJ; Kim, CC; Kim, H; Kim, MJ; Kim, Y; Kim, YH; Kim, YT; Kimoto, E; Kiyu, A; Klatt, N; Kobayashi, M; Koh, J; Köhler, R; Kondadasula, SV; Kong, H; Kong, W; Kong, X; Kotidis, A; Kotwal, A; Kouvari, M; Kozhinov, AN; Kruger, D; Kuang, S; Kuang, Y; Kubota, M; Kuklik, P; Kumar, P; Kumar, SK; Kuo, YF; Kurup, SP; Kusuhara, H; Kuswanto, H; Lacouture, ME; Lambin, P; Lang, CC; Langroudi, FH; Lanman, RB; Larsen, OH; Laskin, J; Le, VH; Leach, M; Lee, BG; Lee, DF; Lee, DS; Lee, HJ; Lee, SB; Lee, YA; Lei, Y; Lekashvili, O; Lelj, F; Lemin, AS; Lemoine, J; Leuschner, R; Li, B; Li, BT; Li, C; Li, D; Li, F; Li, G; Li, H; Li, HW; Li, J; Li, M; Li, P; Li, Q; Li, S; Li, W; Li, X; Li, XY; Li, Y; Li, Z; Lian, Y; Liang, C; Liao, J; Liao, W; Liao, Y; Lin, D; Lin, W; Lin, YL; Lindbäck, J; Lindsay, AP; Ling, J; Linser, PJ; Liu, C; Liu, H; Liu, JJ; Liu, L; Liu, Q; Liu, SF; Liu, X; Liu, Y; Liu, Z; Liu, ZM; Lo Sterzo, C; Lo, ECM; Lobchuk, MM; Lodge, TP; Logotheti, S; Lonial, S; Lopes, G; Lopes, RD; Lopez, J; Lopez, SA; López-Santos, AL; López-Sendón, JL; Loring, Z; Louis, C; Lovita, AND; Lu, DZ; Lu, H; Lu, J; Lu, K; Lu, TT; Lu, Y; Luengo, A; Lum, LG; Luna, JM; Luo, L; Luo, R; Luo, T; Luo, X; Luo, Z; Lv, B; Lymperopoulos, N; Lyras, A; Lyu, Y; M Kannan, A; Ma, H; Ma, M; Ma, Q; Ma, S; Ma, WY; Ma, Y; Maalouf, E; Machado, FA; Maeda, K; Magrans, JO; Maharani, A; Maia, G; Mainwaring, RD; Maji, TK; Majumdar, K; Mannarino, MR; Mansuri, MS; Marinescu, SC; Markatos, G; Marquardt, S; Marraiki, N; Martens, C; Martínez, TJ; Marumo, K; Maruyama, H; Marwani, HM; Marzo, I; Masrati, G; Matamba, P; Mathialagan, S; Matys, J; Mayatra, JM; Mboua, PC; McArthur, T; McCrimmon, RJ; McIntosh, S; McSpadden, S; Medina-Campos, ON; Medvedovsky, AT; Mei, Z; Mekontso-Dessap, A; Menezes, AMB; Meng, J; Meng, P; Meng, Y; Menter, A; Mets, MB; Mets-Halgrimson, R; Metzger, T; Metzler-Nolte, N; Meyer, C; Mi, Y; Michailoviene, V; Mikrogeorgiou, A; Militz, H; Miller Iii, TF; Minarowska, A; Mir, S; Miron, I; Miyake, T; Moayer, F; Modi, S; Moeller, SJ; Mohamad, MN; Mohammed, EHM; Mokhonov, VV; Mondal, A; Moore, J; Moravcova, M; Mordi, IR; Mordi, NA; Mortensen, NP; Moscariello, C; Moser, J; Moynahan, ME; Mu, J; Mu, W; Mudduwa, LKB; Mukherjee, S; Mukhtar, A; Mulkey, DK; Murr, N; Mushtaq, Z; Muthuswamy, N; Mutlu, O; Muto, C; Myroforou, I; Na, KJ; Nabi, M; Nagornov, KO; Nagy, RJ; Naik, A; Nakajima, K; Nam, KT; Nam, YW; Namburath, M; Nammour, S; Namour, A; Namour, M; Nanan, S; Natsume, H; Nave, S; Naveed, A; Nazir, H; Ndubaku, C; Nedospasov, SA; Neradilek, MB; Newcomb, C; Nguépy Keubo, FR; Nguyen, M; Ning, J; Ning, Q; Noguchi, S; Nordahl, SHG; Nordfalk, KF; Norton, L; Noupoue, EM; Nouri, SS; Nowak, JK; Núñez, K; Oakes, K; Odegaard, JI; Ogorodnikova, OL; Ogunsuyi, O; Oh, HK; Oh, HR; Oh, KH; Ohgi, K; Okunade, KS; Oliveira, AG; Olorunfemi, G; Olsen, ML; Olson, BA; Omari, KW; Ondruschka, B; Orfali, R; Orkopoulos, A; Orlowski, RZ; Oser, SM; Oser, TK; Özcan, M; Padilla, V; Paeng, JC; Pajuelo-Lozano, N; Pal, SK; Palmieri, S; Palomeque, E; Pan, W; Panagiotakos, DB; Pandey, M; Pang, D; Pang, Q; Pangarah, CA; Panny, A; Paparella, A; Papirio, S; Papouskova, K; Parang, K; Park, HJ; Park, IK; Park, S; Parker, TL; Parkhomenko, A; Parmon, VN; Parsons, B; Parsons, J; Patel, PR; Patil, S; Patsourakos, NG; Patterson, KC; Pavlidis, P; Pedernera, M; Pedersen, R; Pedraza-Chaverri, J; Pellegrini, M; Peña-Chora, G; Pereira, EDM; Pereira, MADS; Peretz, A; Perez-Padilla, R; Perlman, GY; Perona, R; Petras, C; Phuntsho, S; Picada, JN; Pinder, TA; Piper, LFJ; Pirozzi, F; Pirro, M; Pleckaityte, M; Ploutz-Snyder, LL; Ploutz-Snyder, R; Pogorzelski, A; Poles, L; Postma, AA; Prager, A; Prakash, J; Punn, R; Pützer, BM; Qi, J; Qi, MC; Qi, Y; Qian, J; Qian, Y; Qiang, L; Qiu, J; Qu, Y; Rabiu, KA; Rahighi, S; Rahman, MM; Rahmani, B; Rajkumar, SV; Ramanathan, R; Raras, TYM; Rashi, Y; Rasool, G; Rathore, MG; Ratnawati, R; Ratola, N; Raucci, U; Ray, SK; Razavi, P; Razazi, K; Razek, S; Razi, SS; Reback, M; Reddy, K; Rees, DC; Reginatto, FH; Reich, H; Reis-Filho, JS; Ren, X; Ren, Y; Renner, G; Rey, G; Reymen, B; Riaz, M; Ricci, A; Richardson, PG; Richter, C; Riga, M; Ritchie, C; Rivoal, S; Roberts, W; Robson, ME; Rocha, GZ; Rodrigues, AD; Rogach, AL; Rojas, A; Rosenberg, A; Rosenberg, E; Rosenheck, RA; Roslan, K; Rothenberger, C; Rouschop, KMA; Rubagumya, F; Ryan, CM; Ryder, JW; Saad, MJA; Sacan, O; Sacchi, A; Sahebkar, A; Saini, A; Sainz, B; Sajo, EA; Sakizadeh, J; Saleh, AA; Salgado Júnior, IB; Salvi, R; Samoylova, YV; Samuni, A; Sanchez, DM; Sanchez-Perez, I; Santos, M; Sarapulova, A; Sardot, T; Saud, N; Sauerbier, P; Scaltriti, M; Schaeffer, B; Schalk, DL; Scherschel, K; Schijven, MP; Schreuder, HWR; Schuhmacher, M; Schultz-Lebahn, A; Schwarzl, J; Scott, JM; Sebayang, SK; Seeger, ZL; Segabinazi Peserico, C; Selenica, P; Serio, A; Seruga, B; Shah, A; Shah, C; Shah, PD; Shahrokh Tehraninezhad, E; Shan, A; Shao, Z; Sharma, AMR; Sharma, RK; Shen, J; Shen, R; Shi, X; Shi, Y; Shi, ZE; Shih, YC; Shimohata, H; Shimpi, N; Shin, SH; Shon, HK; Shuvy, M; Siddique, AB; Siegbahn, A; Sikandar, M; Silvani, Y; Singh, A; Singh, AK; Singh, D; Singh, JS; Singh, KP; Singh, M; Situ, B; Skipper, MT; Skouloudi, M; Sloane, BF; Smyrnioudis, N; Snyder, MA; Söhnchen, C; Solis Condor, R; Solit, DB; Someya, S; Song, H; Song, J; Song, W; Song, Y; Sorokina, KN; Soshi, S; Soyer, P; Spitschak, A; Sreekrishnan, TR; Srinivasan, M; Staruschenko, A; Steel, A; Stefan-van Staden, RI; Stein, AM; Strayer, H; Struthers, AD; Su, H; Su, Q; Su, X; Sudore, RL; Sugimura, H; Sugiyama, Y; Sujuti, H; Sumner, SJ; Sun, B; Sun, D; Sun, H; Sun, J; Sun, JY; Sun, X; Sun, Y; Sun, Z; Sung, YC; Surenaud, M; Sutimantanapi, D; Suwandaratne, NS; Swaroop, S; Sychrova, H; Syed, A; Szczepanik, M; Szederjesi, J; Szodorai, R; Tacy, TA; Tadelle, RM; Takayasu, M; Tammeveski, K; Tan, H; Tan, M; Tang, HX; Tang, S; Tang, X; Tanokura, M; Tao, F; Tao, H; Tarafdari, A; Tarín-Carrasco, P; Tasson Tatang, C; Teixeira, JP; Thakur, A; Theobald, A; Thevenot, P; Thomaidis, K; Tian, J; Tillib, SV; Toma, C; Tomita, M; Tonchev, I; Tong, F; Toy, W; Trypuć, M; Tselepis, AD; Tsetseris, L; Tsikouri, GE; Tsikouris, EI; Tsoplifack, CB; Tsoumani, ME; Tsujimoto, R; Tsybin, YO; Tu, J; Tu, TM; Turco, M; Turkyilmaz, IB; Uddin, MJ; Ung, J; Unsihuay, D; Utsunomiya, T; Vagenende, B; Vaishnav, J; Valdes, C; Validad, MH; Valle, J; van Ginkel, MPH; van Grevenstein, WMU; Vanderpuye, V; Vasan, N; Vasilenko, EA; Vasques, GJ; Vavoulis, P; Verani, A; Veziroglu, E; Viegas, A; Vitali, MG; Vitsas, G; Voccio, JP; Vogiatzidis, C; Volow, A; Volpin, F; Vourvahis, M; Wagner, LI; Walkowiak, J; Wallace, R; Wallentin, L; Wan, D; Wan, L; Wan, T; Wang, C; Wang, F; Wang, FN; Wang, H; Wang, J; Wang, L; Wang, Q; Wang, S; Wang, T; Wang, W; Wang, X; Wang, XW; Wang, Y; Wang, YS; Wang, Z; Ward, J; Ward, L; Waseem, R; Watson, DF; Weber, P; Wehrmeister, FC; Wei, CH; Wei, H; Wei, L; Wei, Q; Wei, Y; Weinstock, RS; Weiss, M; Welborn, M; Wen, L; Wen, LM; Wen, Q; Wen, Z; Wesseling, P; Westerbergh, J; White, K; Wick, MP; Willems, S; Wiyasa, IWA; Wójciak, R; Wolkenhauer, O; Won, HH; Wong, J; Woo, YC; Wood, LS; Wu, CT; Wu, CY; Wu, D; Wu, G; Wu, J; Wu, K; Wu, M; Wu, Q; Wu, T; Wu, W; Wu, X; Wu, XT; Wu, Y; Xi, D; Xi, J; Xiang, W; Xiang, Y; Xiao, M; Xiao, Z; Xie, H; Xie, Q; Xie, S; Xie, X; Xing, M; Xing, YL; Xu, C; Xu, X; Xu, Y; Xu, Z; Xue, F; Xue, XD; Yaglioglu, HG; Yamada, H; Yamashita, M; Yan, W; Yan, Z; Yanardag, R; Yang, D; Yang, H; Yang, K; Yang, QQ; Yang, R; Yang, S; Yang, T; Yang, X; Yang, Y; Yao, H; Yao, Y; Yari, D; Yassin, MT; Ye, C; Ye, J; Ye, Q; Yildiz, EA; Ying, S; Yoon, H; Yu, D; Yu, K; Yu, N; Yu, PL; Yuan, C; Yuan, D; Yuan, LJ; Yuan, Z; Yuen, N; Zagatto, AM; Zakaria, Y; Zalewski, AM; Zamora, S; Zavorotinskaya, T; Zeid, JL; Zeinoun, T; Zeng, C; Zerby, HN; Zhan, X; Zhang, A; Zhang, D; Zhang, E; Zhang, F; Zhang, H; Zhang, J; Zhang, L; Zhang, M; Zhang, P; Zhang, Q; Zhang, QY; Zhang, RG; Zhang, S; Zhang, T; Zhang, X; Zhang, Y; Zhang, YY; Zhao, CK; Zhao, H; Zhao, J; Zhao, K; Zhao, Q; Zhao, S; Zhao, T; Zhao, XQ; Zhao, Y; Zhao, Z; Zheng, J; Zheng, L; Zheng, Y; Zhou, B; Zhou, G; Zhou, L; Zhou, T; Zhou, X; Zhu, C; Zhu, J; Zhu, Y; Zhu, ZQ; Zhuang, T; Zimmermannova, O; Zin, NNINM; Zisimos, K; Zoghebi, KA; Zonder, JA; Zou, C; Zwirner, J1
Carneiro-Ramos, MS; da Silva Martinho, H; Junho, CVC; Nepomuceno, G1
Bami, E; Cirakli, Z; Ercan, F; Izzettin, FV; Köroglu, K; Okuyan, B; Ozakpınar, OB; Ozdemir-Kumral, ZN; Sancar, M; Sekerler, T1
Adeghate, E; Kader, KH; Kumaraswamy, SM; Mahgoub, E; Ojha, S; Rajesh, M; Venkataraman, B1
Aoudjit, L; Eremina, V; Hardy, WR; Jones, N; Martin, CE; Petersen, KA; Quaggin, SE; Takano, T; Tilak, M1
Shah, I1
Prieto-Sánchez, S; Ruiz-Gómez, M; Tutor, AS1
Bagga, A; Dinda, AK; Sharma, A; Singh, G; Singh, L; Sinha, A1
Estes, AM; Fang, XR; Gonzalez, FJ; Jennings, BL; Kanu, A; Malik, KU; Moore, JA; Pingili, AK1
Andersson, HC1
Eric Wang, W; Guan, W; Han, Y; Liu, Y; Ren, H; Wang, Z; Yang, J; Zeng, C; Zhou, L1
Abouelsaad, M; Bian, Z; Cowden, D; Cui, Y; Das, AS; Kofskey, D; Kong, Q; Kresak, A; O'Toole, J; Petersen, RB; Sedor, J; Siedlak, S; Tan, T; Wang, GX; Wang, X; Warren, M; Wyza, RE; Yuan, J; Zeng, L; Zhang, B; Zhang, F; Zhou, X; Zhu, H; Zhu, X; Zou, WQ1
Siciliano, SD; Weber, LP; Wildemann, TM1
Chen, H; Li, Y; Yu, YN1
Hilton, G; Johnson, CP; Liang, HL; Mortensen, J; Nilakantan, V; Regner, K1
Bonventre, JV; Brown, RP; Espandiari, P; Goering, PL; Hanig, JP; Keenan, J; Kilty, CG; Sadrieh, N; Shaw, M; Vaidya, VS; Zhang, J1
Bátkai, S; Gao, B; Haskó, G; Mukhopadhyay, B; Mukhopadhyay, P; Pacher, P; Pan, H; Patel, V; Rajesh, M1
Maksimchyk, Y; Obrosova, IG; Shevalye, H; Watcho, P1
Amoresano, A; Galli, F; Palmese, A; Pilolli, F; Piroddi, M; Pucci, P; Ronco, C1
Bongartz, LG; Braam, B; Cramer, MJ; Doevendans, PA; Gaillard, CA; Goldschmeding, R; Joles, JA; Steendijk, P; Verhaar, MC1
Asano, A; Kimoto, Y; Masuda, A; Nishinohara, M; Ochi, T; Sugiyama, A; Takeuchi, T1
Baylis, C; Moningka, NC; Muller-Delp, JM; Sindler, AL1
Catanzaro, R; Harada, M; Jain, S; Kumari, A; Marotta, F; Minelli, E; Solimene, U1
Abdelkader, A; Broughton, BR; Ding, A; Evans, RG; Kalaignanasundaram, P; Kim, HB; Phillips, JK; Ricardo, SD; Witting, PK; Wyse, BF1
Aypar, U; Orhan, H; Sahin, A; Sahin, G; Vermeulen, NP1
Chen, CP; Kitani, K; Park, JC; Rhyu, DY; Tanaka, T; Yokozawa, T1
Brown, PA; Chatterjee, PK; Cuzzocrea, S; Mota-Filipe, H; Stewart, KN; Thiemermann, C; Zacharowski, K1
Kirschbaum, B1
Brown, PA; Chatterjee, BE; Chatterjee, PK; Cuzzocrea, S; Mota-Filipe, H; Patel, NS; Serraino, I; Stewart, KN; Thiemermann, C1
Borderie, D; Drüeke, TB; Ekindjian, OG; Lacour, B; Massy, ZA; Nguyen-Khoa, T1
Cuniberti, LA; Dominguez, GN; Fischer, PA; Martinez, V; Masnatta, LD; Ramirez, AJ; Werba, JP1
Britti, D; Brown, PA; Chatterjee, PK; Cuzzocrea, S; Dugo, L; Kvale, EO; Mota-Filipe, H; Patel, NS; Sivarajah, A; Stewart, KN; Thiemermann, C; Yaqoob, MM1
Barrera, D; Hernández-Pando, R; Ibarra-Rubio, ME; Maldonado, PD; Medina-Campos, ON; Pedraza-Chaverrí, J; Pedraza-Chaverrrí, J1
FRITZELL, S; JAGENBURG, OR; SCHNUERER, LB1
ALAGILLE, D; GENTIL, C1
GENTZ, J; JAGENBURG, R; ZETTERSTROEM, R1
Barrera, D; Castro, L; Chirino, YI; Hernández-Pando, R; Macías-Ruvalcaba, NA; Maldonado, PD; Medina-Campos, ON; Pedraza-Chaverrí, J; Salcedo, MI1
Chirino, YI; Hernández-Pando, R; Pedraza-Chaverrí, J1
Alam, T; Chang, Z; Colburn, M; Fechner, JH; Golner, S; Hamawy, MM; Hu, H; Kanmaz, T; Kim, HT; Knechtle, SJ; Oberley, T; Roenneburg, D; Scheunemann, T; Torrealba, JR1
Akkari, Y; Al-Dhalimy, M; Finegold, M; Fleming, WH; Grompe, M; Held, PK; Jiang, S; Olson, S; Torimaru, Y; Willenbring, H1
McKiernan, PJ1
Abraham, NG; Botros, FT; Drummond, G; Goodman, AI; Olszanecki, R; Omura, S; Rezzani, R; Rodella, L; Stec, DE1
Alexander, KP; Chen, AY; Gibler, WB; Hochman, JS; Newby, LK; Ohman, EM; Peterson, ED; Redberg, RF; Roe, MT; Schwartz, JB1
Hotter, G; Palacios, L; Pi, F; Sola, A; Viñas, JL1
Fujimoto, S; Haruna, Y; Kashihara, N; Komai, N; Namikoshi, T; Ohzeki, M; Sasaki, T; Tomita, N; Yoshida, A1
Haruna, Y; Kashihara, N; Kobayashi, S; Komai, N; Namikoshi, T; Sasaki, T; Satoh, M; Tomita, N1
Coimbra, TM; Costa, RS; da Silva, CG; de Jesus Soares, T; Francescato, HD; Volpini, RA1
Bobadilla, NA; Chirino, YI; Cruz, C; Martínez-Martínez, CM; Pedraza-Chaverri, J; Sánchez-González, DJ; Trujillo, J1
Halvorsen, S1
Gentz, J; Levy, L; Lindblad, B; Lindstedt, S; Shasteen, W; Zetterstrom, R1
Bert, JK; Moore, KE; Wright, PF1
Fällström, SP; Lindblad, B; Steen, G1
Holmberg, C; Kärkkäinen, J; Krogerus, L; Laine, J; Salo, MK; Wahlroos, O1
Bentkowski, Z; Holme, E; Lindstedt, S; Pronicka, E; Rowinska, E; Zawadzki, J1
D'Angata, ID; Paradis, K1
Donnenberg, MS; Palmer, LM; Reilly, TJ; Utsalo, SJ1
Brosstad, F; Goggin, T; Lehne, G; Midtvedt, K; Nordal, KP1
Anthony, GM; Bank, N; Kiroycheva, M; Singhal, PC; Southan, GJ; Szabo, C1
Berger, R; Caglar, M; Coşkun, T; Koçak, N; Ozalp, I; Yüce, A1
Bergan, A; Flatmark, A; Gjone, E; Halvorsen, S; Jellum, E; Kvittingen, EA; Schrumpf, E; Stokke, O; Sødal, G1
Thorn, L1
Aber, GM; McGale, EH; Pickford, JC2
Hruban, Z; Jevtic, MM; Thorp, FK1
Atkins, RJ; Holston, JL; Hosty, TS; Levy, HL; Patton, TH; Tomlin, GA1
Gwinn, JL; Lee, FA1
Keterlers, JY; Warembourg, H1
Bernard, P; Fenasse, R; Laurent, B; Lissitzky, S1
Gjessing, LR; Halvorsen, S; Loken, AC; Pande, H1

Reviews

1 review(s) available for tyrosine and Kidney Diseases

ArticleYear
Psychological distress among health care professionals of the three COVID-19 most affected Regions in Cameroon: Prevalence and associated factors.
    Annales medico-psychologiques, 2021, Volume: 179, Issue:2

    Topics: 3' Untranslated Regions; 5'-Nucleotidase; A549 Cells; Accidental Falls; Acetylcholinesterase; Acrylic Resins; Actinobacillus; Acute Disease; Acute Kidney Injury; Adaptor Proteins, Signal Transducing; Adenosine; Adenosine Triphosphate; Administration, Inhalation; Administration, Oral; Adolescent; Adult; Advance Care Planning; Africa, Northern; Age Factors; Aged; Aged, 80 and over; Air Pollutants; Air Pollution; Air Pollution, Indoor; Albendazole; Aluminum Oxide; Anastomosis, Surgical; Ancylostoma; Ancylostomiasis; Androstadienes; Angiogenesis Inhibitors; Angiotensin II; Animals; Anti-Bacterial Agents; Anti-Infective Agents; Antibodies, Bispecific; Antibodies, Viral; Anticoagulants; Antihypertensive Agents; Antinematodal Agents; Antineoplastic Agents; Antineoplastic Agents, Immunological; Antineoplastic Combined Chemotherapy Protocols; Antioxidants; Antiporters; Antiviral Agents; Apoptosis; Aptamers, Nucleotide; Aromatase Inhibitors; Asian People; Astrocytes; Atrial Fibrillation; Auditory Threshold; Aurora Kinase B; Australia; Autophagy; Autophagy-Related Protein 5; Autotrophic Processes; Bacillus cereus; Bacillus thuringiensis; Bacterial Proteins; Beclin-1; Belgium; Benzene; Benzene Derivatives; Benzhydryl Compounds; beta Catenin; beta-Arrestin 2; Biliary Tract Diseases; Biofilms; Biofuels; Biomarkers; Biomarkers, Tumor; Biomass; Biomechanical Phenomena; Bioreactors; Biosensing Techniques; Biosynthetic Pathways; Bismuth; Blood Platelets; Bone and Bones; Bone Regeneration; Bortezomib; Botulinum Toxins, Type A; Brain; Brain Injuries; Brain Ischemia; Brain Neoplasms; Breast Neoplasms; Breath Tests; Bronchodilator Agents; Calcium Phosphates; Cannabis; Carbon Dioxide; Carbon Isotopes; Carcinogenesis; Carcinoma, Hepatocellular; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Cardiac Resynchronization Therapy; Cardiac Resynchronization Therapy Devices; Cardiomyopathies; Cardiovascular Diseases; Cariostatic Agents; Case Managers; Case-Control Studies; Catalysis; Cation Transport Proteins; CD8-Positive T-Lymphocytes; Cecropia Plant; Cell Adhesion; Cell Count; Cell Differentiation; Cell Division; Cell Line; Cell Line, Tumor; Cell Membrane; Cell Movement; Cell Proliferation; Cell Self Renewal; Cell Survival; Cells, Cultured; Cellular Reprogramming; Cellulose; Charcoal; Chemical and Drug Induced Liver Injury; Chemical Phenomena; Chemokines; Chemoradiotherapy; Chemoreceptor Cells; Child; Child Abuse; Child, Preschool; China; Chlorogenic Acid; Chloroquine; Chromatography, Gas; Chronic Disease; Clinical Competence; Coated Materials, Biocompatible; Cochlea; Cohort Studies; Color; Comorbidity; Computer Simulation; Computer-Aided Design; Contraception; Contraceptive Agents, Female; Contrast Media; COP-Coated Vesicles; Coronavirus Infections; Cost of Illness; Coturnix; COVID-19; Creatinine; Cross-Over Studies; Cross-Sectional Studies; Culex; Curriculum; Cyclic N-Oxides; Cytokines; Cytoplasm; Cytotoxicity, Immunologic; Cytotoxins; Databases, Factual; Deep Learning; Delivery, Obstetric; Denitrification; Dental Caries; Denture, Complete; Dexamethasone; Diabetes Complications; Diabetes Mellitus; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Dielectric Spectroscopy; Diet, High-Fat; Dietary Fiber; Disease Models, Animal; Disease Progression; DNA; DNA Copy Number Variations; DNA, Mitochondrial; Dog Diseases; Dogs; Dopaminergic Neurons; Double-Blind Method; Down-Regulation; Doxorubicin; Drug Carriers; Drug Design; Drug Interactions; Drug Resistance, Bacterial; Drug Resistance, Neoplasm; Drug-Related Side Effects and Adverse Reactions; Drugs, Chinese Herbal; Dry Powder Inhalers; Dust; E2F1 Transcription Factor; Ecosystem; Education, Nursing; Education, Nursing, Baccalaureate; Electric Impedance; Electricity; Electrocardiography; Electrochemical Techniques; Electrochemistry; Electrodes; Electrophoresis, Polyacrylamide Gel; Endoplasmic Reticulum; Endothelial Cells; Environmental Monitoring; Enzyme Inhibitors; Epithelial Cells; Epithelial-Mesenchymal Transition; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Estrogen Receptor Modulators; Europe; Evoked Potentials, Auditory, Brain Stem; Exosomes; Feasibility Studies; Female; Ferricyanides; Ferrocyanides; Fibrinogen; Finite Element Analysis; Fistula; Fluorescent Dyes; Fluorides, Topical; Fluorodeoxyglucose F18; Fluticasone; Follow-Up Studies; Food Contamination; Food Microbiology; Foods, Specialized; Forensic Medicine; Frail Elderly; France; Free Radicals; Fresh Water; Fungi; Fungicides, Industrial; Galactosamine; Gastrointestinal Neoplasms; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Gene Frequency; Genetic Predisposition to Disease; Genotype; Gingival Hemorrhage; Glioblastoma; Glioma; Glomerular Filtration Rate; Glomerulosclerosis, Focal Segmental; Glucose; Glucose Transport Proteins, Facilitative; Glucosides; Glutamine; Glycolysis; Gold; GPI-Linked Proteins; Gram-Negative Bacteria; Gram-Positive Bacteria; Graphite; Haplotypes; HCT116 Cells; Healthy Volunteers; Hearing Loss; Heart Failure; Hedgehog Proteins; HEK293 Cells; HeLa Cells; Hemodynamics; Hemorrhage; Hepatocytes; Hippo Signaling Pathway; Histone Deacetylases; Homeostasis; Hospital Mortality; Hospitalization; Humans; Hydantoins; Hydrazines; Hydrogen Peroxide; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Hydroxylamines; Hypoglycemic Agents; Immunity, Innate; Immunoglobulin G; Immunohistochemistry; Immunologic Factors; Immunomodulation; Immunophenotyping; Immunotherapy; Incidence; Indazoles; Indonesia; Infant; Infant, Newborn; Infarction, Middle Cerebral Artery; Inflammation; Injections, Intramuscular; Insecticides; Insulin-Like Growth Factor I; Insurance, Health; Intention to Treat Analysis; Interleukin-1 Receptor-Associated Kinases; Interleukin-6; Intrauterine Devices; Intrauterine Devices, Copper; Iron; Ischemia; Jordan; Keratinocytes; Kidney; Kidney Diseases; Kir5.1 Channel; Klebsiella Infections; Klebsiella pneumoniae; Lab-On-A-Chip Devices; Laparoscopy; Lasers; Lasers, Semiconductor; Lenalidomide; Leptin; Lethal Dose 50; Levonorgestrel; Limit of Detection; Lipid Metabolism; Lipid Metabolism Disorders; Lipogenesis; Lipopolysaccharides; Liquid Biopsy; Liver; Liver Abscess, Pyogenic; Liver Cirrhosis; Liver Diseases; Liver Neoplasms; Longevity; Lung Neoplasms; Luteolin; Lymph Nodes; Lymphocyte Activation; Macaca fascicularis; Macrophages; Mad2 Proteins; Magnetic Resonance Imaging; Male; Mammary Glands, Human; Manganese; Manganese Compounds; MAP Kinase Signaling System; Materials Testing; Maternal Health Services; MCF-7 Cells; Medicaid; Medicine, Chinese Traditional; Melanoma; Membrane Proteins; Mental Health; Mercury; Metal Nanoparticles; Metals, Heavy; Metformin; Methionine Adenosyltransferase; Mice; Mice, Inbred BALB C; Mice, Inbred C3H; Mice, Inbred C57BL; Mice, Inbred CBA; Mice, Knockout; Mice, Nude; Microalgae; Microbial Sensitivity Tests; Microglia; MicroRNAs; Microscopy, Atomic Force; Microscopy, Electron, Scanning; Middle Aged; Mitochondria; Mitochondrial Proteins; Mitral Valve; Mitral Valve Insufficiency; Models, Anatomic; Molecular Structure; Molybdenum; Monocarboxylic Acid Transporters; Moths; MPTP Poisoning; Multigene Family; Multiparametric Magnetic Resonance Imaging; Multiple Myeloma; Muscle, Skeletal; Mutagens; Mutation; Myeloid Cells; Nanocomposites; Nanofibers; Nanomedicine; Nanoparticles; Nanowires; Neoadjuvant Therapy; Neomycin; Neoplasm Grading; Neoplasm Recurrence, Local; Neoplasms; Neoplastic Stem Cells; Neostriatum; Neovascularization, Pathologic; Netherlands; Neuromuscular Agents; Neurons; NF-E2-Related Factor 2; NF-kappa B; Nickel; Nitrogen Oxides; Non-alcoholic Fatty Liver Disease; Nucleosides; Nucleotidyltransferases; Nutritional Status; Obesity, Morbid; Ofloxacin; Oils, Volatile; Oligopeptides; Oncogene Protein v-akt; Optical Imaging; Organic Cation Transport Proteins; Organophosphonates; Osteoarthritis; Osteoarthritis, Hip; Osteoarthritis, Knee; Osteoblasts; Osteogenesis; Oxidation-Reduction; Oxidative Stress; Oxides; Oxygen Isotopes; Pancreas; Pancreaticoduodenectomy; Pandemics; Particle Size; Particulate Matter; Patient Acceptance of Health Care; Patient Compliance; PC-3 Cells; Peptide Fragments; Peptides; Periodontal Attachment Loss; Periodontal Index; Periodontal Pocket; Periodontitis; Peroxides; Peru; Pest Control, Biological; Phosphatidylinositol 3-Kinase; Phosphatidylinositol 3-Kinases; Phylogeny; Pilot Projects; Piperidines; Plant Bark; Plant Extracts; Plant Leaves; Plasmids; Platelet Function Tests; Pneumonia, Viral; Podocytes; Poly (ADP-Ribose) Polymerase-1; Poly(ADP-ribose) Polymerase Inhibitors; Polyethylene Terephthalates; Polymers; Polymorphism, Single Nucleotide; Porosity; Portugal; Positron-Emission Tomography; Postoperative Complications; Postural Balance; Potassium Channels, Inwardly Rectifying; Povidone; Powders; Precancerous Conditions; Precision Medicine; Predictive Value of Tests; Pregnancy; Prenatal Care; Prognosis; Promoter Regions, Genetic; Prospective Studies; Prostatectomy; Prostatic Neoplasms; Proteasome Inhibitors; Protective Agents; Protein Binding; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases; Protein Transport; Proto-Oncogene Proteins B-raf; Proto-Oncogene Proteins c-akt; Psychiatric Nursing; PTEN Phosphohydrolase; Pulmonary Embolism; Pyrimethamine; Radiopharmaceuticals; Rats; Rats, Sprague-Dawley; Rats, Wistar; Reactive Oxygen Species; Receptor, ErbB-2; Receptor, IGF Type 1; Receptors, Estrogen; Receptors, G-Protein-Coupled; Recombinational DNA Repair; Recovery of Function; Regional Blood Flow; Renal Dialysis; Renin; Renin-Angiotensin System; Reperfusion Injury; Reproducibility of Results; Republic of Korea; Respiratory Distress Syndrome; Retrospective Studies; Rhodamines; Risk Assessment; Risk Factors; RNA, Long Noncoding; RNA, Messenger; Running; Saccharomyces cerevisiae; Saccharomyces cerevisiae Proteins; Salinity; Salmeterol Xinafoate; Sarcoma; Seasons; Shoulder Injuries; Signal Transduction; Silicon Dioxide; Silver; Sirtuin 1; Sirtuins; Skull Fractures; Social Determinants of Health; Sodium; Sodium Fluoride; Sodium Potassium Chloride Symporter Inhibitors; Sodium-Glucose Transporter 2 Inhibitors; Soil; Soil Pollutants; Spain; Spectrophotometry; Spectroscopy, Fourier Transform Infrared; Staphylococcal Protein A; Staphylococcus aureus; Stem Cells; Stereoisomerism; Stomach Neoplasms; Streptomyces; Strontium; Structure-Activity Relationship; Students, Nursing; Substance-Related Disorders; Succinic Acid; Sulfur; Surface Properties; Survival Rate; Survivin; Symporters; T-Lymphocytes; Temozolomide; Tensile Strength; Thiazoles; Thiobacillus; Thiohydantoins; Thiourea; Thrombectomy; Time Factors; Titanium; Tobacco Mosaic Virus; Tobacco Use Disorder; Toll-Like Receptor 4; Toluene; Tomography, X-Ray Computed; TOR Serine-Threonine Kinases; Toxicity Tests, Acute; Toxicity Tests, Subacute; Transcriptional Activation; Treatment Outcome; Troponin I; Tumor Cells, Cultured; Tumor Escape; Tumor Hypoxia; Tumor Microenvironment; Tumor Necrosis Factor Inhibitors; Tumor Necrosis Factor-alpha; Tyrosine; Ubiquitin-Protein Ligases; Ubiquitination; Ultrasonic Waves; United Kingdom; United States; United States Department of Veterans Affairs; Up-Regulation; Urea; Uric Acid; Urinary Bladder Neoplasms; Urinary Bladder, Neurogenic; Urine; Urodynamics; User-Computer Interface; Vemurafenib; Verbenaceae; Veterans; Veterans Health; Viral Load; Virtual Reality; Vitiligo; Water Pollutants, Chemical; Wildfires; Wnt Signaling Pathway; Wound Healing; X-Ray Diffraction; Xenograft Model Antitumor Assays; Xylenes; Young Adult; Zinc; Zinc Oxide; Zinc Sulfate; Zoonoses

2021

Trials

2 trial(s) available for tyrosine and Kidney Diseases

ArticleYear
Psychological distress among health care professionals of the three COVID-19 most affected Regions in Cameroon: Prevalence and associated factors.
    Annales medico-psychologiques, 2021, Volume: 179, Issue:2

    Topics: 3' Untranslated Regions; 5'-Nucleotidase; A549 Cells; Accidental Falls; Acetylcholinesterase; Acrylic Resins; Actinobacillus; Acute Disease; Acute Kidney Injury; Adaptor Proteins, Signal Transducing; Adenosine; Adenosine Triphosphate; Administration, Inhalation; Administration, Oral; Adolescent; Adult; Advance Care Planning; Africa, Northern; Age Factors; Aged; Aged, 80 and over; Air Pollutants; Air Pollution; Air Pollution, Indoor; Albendazole; Aluminum Oxide; Anastomosis, Surgical; Ancylostoma; Ancylostomiasis; Androstadienes; Angiogenesis Inhibitors; Angiotensin II; Animals; Anti-Bacterial Agents; Anti-Infective Agents; Antibodies, Bispecific; Antibodies, Viral; Anticoagulants; Antihypertensive Agents; Antinematodal Agents; Antineoplastic Agents; Antineoplastic Agents, Immunological; Antineoplastic Combined Chemotherapy Protocols; Antioxidants; Antiporters; Antiviral Agents; Apoptosis; Aptamers, Nucleotide; Aromatase Inhibitors; Asian People; Astrocytes; Atrial Fibrillation; Auditory Threshold; Aurora Kinase B; Australia; Autophagy; Autophagy-Related Protein 5; Autotrophic Processes; Bacillus cereus; Bacillus thuringiensis; Bacterial Proteins; Beclin-1; Belgium; Benzene; Benzene Derivatives; Benzhydryl Compounds; beta Catenin; beta-Arrestin 2; Biliary Tract Diseases; Biofilms; Biofuels; Biomarkers; Biomarkers, Tumor; Biomass; Biomechanical Phenomena; Bioreactors; Biosensing Techniques; Biosynthetic Pathways; Bismuth; Blood Platelets; Bone and Bones; Bone Regeneration; Bortezomib; Botulinum Toxins, Type A; Brain; Brain Injuries; Brain Ischemia; Brain Neoplasms; Breast Neoplasms; Breath Tests; Bronchodilator Agents; Calcium Phosphates; Cannabis; Carbon Dioxide; Carbon Isotopes; Carcinogenesis; Carcinoma, Hepatocellular; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Cardiac Resynchronization Therapy; Cardiac Resynchronization Therapy Devices; Cardiomyopathies; Cardiovascular Diseases; Cariostatic Agents; Case Managers; Case-Control Studies; Catalysis; Cation Transport Proteins; CD8-Positive T-Lymphocytes; Cecropia Plant; Cell Adhesion; Cell Count; Cell Differentiation; Cell Division; Cell Line; Cell Line, Tumor; Cell Membrane; Cell Movement; Cell Proliferation; Cell Self Renewal; Cell Survival; Cells, Cultured; Cellular Reprogramming; Cellulose; Charcoal; Chemical and Drug Induced Liver Injury; Chemical Phenomena; Chemokines; Chemoradiotherapy; Chemoreceptor Cells; Child; Child Abuse; Child, Preschool; China; Chlorogenic Acid; Chloroquine; Chromatography, Gas; Chronic Disease; Clinical Competence; Coated Materials, Biocompatible; Cochlea; Cohort Studies; Color; Comorbidity; Computer Simulation; Computer-Aided Design; Contraception; Contraceptive Agents, Female; Contrast Media; COP-Coated Vesicles; Coronavirus Infections; Cost of Illness; Coturnix; COVID-19; Creatinine; Cross-Over Studies; Cross-Sectional Studies; Culex; Curriculum; Cyclic N-Oxides; Cytokines; Cytoplasm; Cytotoxicity, Immunologic; Cytotoxins; Databases, Factual; Deep Learning; Delivery, Obstetric; Denitrification; Dental Caries; Denture, Complete; Dexamethasone; Diabetes Complications; Diabetes Mellitus; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Dielectric Spectroscopy; Diet, High-Fat; Dietary Fiber; Disease Models, Animal; Disease Progression; DNA; DNA Copy Number Variations; DNA, Mitochondrial; Dog Diseases; Dogs; Dopaminergic Neurons; Double-Blind Method; Down-Regulation; Doxorubicin; Drug Carriers; Drug Design; Drug Interactions; Drug Resistance, Bacterial; Drug Resistance, Neoplasm; Drug-Related Side Effects and Adverse Reactions; Drugs, Chinese Herbal; Dry Powder Inhalers; Dust; E2F1 Transcription Factor; Ecosystem; Education, Nursing; Education, Nursing, Baccalaureate; Electric Impedance; Electricity; Electrocardiography; Electrochemical Techniques; Electrochemistry; Electrodes; Electrophoresis, Polyacrylamide Gel; Endoplasmic Reticulum; Endothelial Cells; Environmental Monitoring; Enzyme Inhibitors; Epithelial Cells; Epithelial-Mesenchymal Transition; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Estrogen Receptor Modulators; Europe; Evoked Potentials, Auditory, Brain Stem; Exosomes; Feasibility Studies; Female; Ferricyanides; Ferrocyanides; Fibrinogen; Finite Element Analysis; Fistula; Fluorescent Dyes; Fluorides, Topical; Fluorodeoxyglucose F18; Fluticasone; Follow-Up Studies; Food Contamination; Food Microbiology; Foods, Specialized; Forensic Medicine; Frail Elderly; France; Free Radicals; Fresh Water; Fungi; Fungicides, Industrial; Galactosamine; Gastrointestinal Neoplasms; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Gene Frequency; Genetic Predisposition to Disease; Genotype; Gingival Hemorrhage; Glioblastoma; Glioma; Glomerular Filtration Rate; Glomerulosclerosis, Focal Segmental; Glucose; Glucose Transport Proteins, Facilitative; Glucosides; Glutamine; Glycolysis; Gold; GPI-Linked Proteins; Gram-Negative Bacteria; Gram-Positive Bacteria; Graphite; Haplotypes; HCT116 Cells; Healthy Volunteers; Hearing Loss; Heart Failure; Hedgehog Proteins; HEK293 Cells; HeLa Cells; Hemodynamics; Hemorrhage; Hepatocytes; Hippo Signaling Pathway; Histone Deacetylases; Homeostasis; Hospital Mortality; Hospitalization; Humans; Hydantoins; Hydrazines; Hydrogen Peroxide; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Hydroxylamines; Hypoglycemic Agents; Immunity, Innate; Immunoglobulin G; Immunohistochemistry; Immunologic Factors; Immunomodulation; Immunophenotyping; Immunotherapy; Incidence; Indazoles; Indonesia; Infant; Infant, Newborn; Infarction, Middle Cerebral Artery; Inflammation; Injections, Intramuscular; Insecticides; Insulin-Like Growth Factor I; Insurance, Health; Intention to Treat Analysis; Interleukin-1 Receptor-Associated Kinases; Interleukin-6; Intrauterine Devices; Intrauterine Devices, Copper; Iron; Ischemia; Jordan; Keratinocytes; Kidney; Kidney Diseases; Kir5.1 Channel; Klebsiella Infections; Klebsiella pneumoniae; Lab-On-A-Chip Devices; Laparoscopy; Lasers; Lasers, Semiconductor; Lenalidomide; Leptin; Lethal Dose 50; Levonorgestrel; Limit of Detection; Lipid Metabolism; Lipid Metabolism Disorders; Lipogenesis; Lipopolysaccharides; Liquid Biopsy; Liver; Liver Abscess, Pyogenic; Liver Cirrhosis; Liver Diseases; Liver Neoplasms; Longevity; Lung Neoplasms; Luteolin; Lymph Nodes; Lymphocyte Activation; Macaca fascicularis; Macrophages; Mad2 Proteins; Magnetic Resonance Imaging; Male; Mammary Glands, Human; Manganese; Manganese Compounds; MAP Kinase Signaling System; Materials Testing; Maternal Health Services; MCF-7 Cells; Medicaid; Medicine, Chinese Traditional; Melanoma; Membrane Proteins; Mental Health; Mercury; Metal Nanoparticles; Metals, Heavy; Metformin; Methionine Adenosyltransferase; Mice; Mice, Inbred BALB C; Mice, Inbred C3H; Mice, Inbred C57BL; Mice, Inbred CBA; Mice, Knockout; Mice, Nude; Microalgae; Microbial Sensitivity Tests; Microglia; MicroRNAs; Microscopy, Atomic Force; Microscopy, Electron, Scanning; Middle Aged; Mitochondria; Mitochondrial Proteins; Mitral Valve; Mitral Valve Insufficiency; Models, Anatomic; Molecular Structure; Molybdenum; Monocarboxylic Acid Transporters; Moths; MPTP Poisoning; Multigene Family; Multiparametric Magnetic Resonance Imaging; Multiple Myeloma; Muscle, Skeletal; Mutagens; Mutation; Myeloid Cells; Nanocomposites; Nanofibers; Nanomedicine; Nanoparticles; Nanowires; Neoadjuvant Therapy; Neomycin; Neoplasm Grading; Neoplasm Recurrence, Local; Neoplasms; Neoplastic Stem Cells; Neostriatum; Neovascularization, Pathologic; Netherlands; Neuromuscular Agents; Neurons; NF-E2-Related Factor 2; NF-kappa B; Nickel; Nitrogen Oxides; Non-alcoholic Fatty Liver Disease; Nucleosides; Nucleotidyltransferases; Nutritional Status; Obesity, Morbid; Ofloxacin; Oils, Volatile; Oligopeptides; Oncogene Protein v-akt; Optical Imaging; Organic Cation Transport Proteins; Organophosphonates; Osteoarthritis; Osteoarthritis, Hip; Osteoarthritis, Knee; Osteoblasts; Osteogenesis; Oxidation-Reduction; Oxidative Stress; Oxides; Oxygen Isotopes; Pancreas; Pancreaticoduodenectomy; Pandemics; Particle Size; Particulate Matter; Patient Acceptance of Health Care; Patient Compliance; PC-3 Cells; Peptide Fragments; Peptides; Periodontal Attachment Loss; Periodontal Index; Periodontal Pocket; Periodontitis; Peroxides; Peru; Pest Control, Biological; Phosphatidylinositol 3-Kinase; Phosphatidylinositol 3-Kinases; Phylogeny; Pilot Projects; Piperidines; Plant Bark; Plant Extracts; Plant Leaves; Plasmids; Platelet Function Tests; Pneumonia, Viral; Podocytes; Poly (ADP-Ribose) Polymerase-1; Poly(ADP-ribose) Polymerase Inhibitors; Polyethylene Terephthalates; Polymers; Polymorphism, Single Nucleotide; Porosity; Portugal; Positron-Emission Tomography; Postoperative Complications; Postural Balance; Potassium Channels, Inwardly Rectifying; Povidone; Powders; Precancerous Conditions; Precision Medicine; Predictive Value of Tests; Pregnancy; Prenatal Care; Prognosis; Promoter Regions, Genetic; Prospective Studies; Prostatectomy; Prostatic Neoplasms; Proteasome Inhibitors; Protective Agents; Protein Binding; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases; Protein Transport; Proto-Oncogene Proteins B-raf; Proto-Oncogene Proteins c-akt; Psychiatric Nursing; PTEN Phosphohydrolase; Pulmonary Embolism; Pyrimethamine; Radiopharmaceuticals; Rats; Rats, Sprague-Dawley; Rats, Wistar; Reactive Oxygen Species; Receptor, ErbB-2; Receptor, IGF Type 1; Receptors, Estrogen; Receptors, G-Protein-Coupled; Recombinational DNA Repair; Recovery of Function; Regional Blood Flow; Renal Dialysis; Renin; Renin-Angiotensin System; Reperfusion Injury; Reproducibility of Results; Republic of Korea; Respiratory Distress Syndrome; Retrospective Studies; Rhodamines; Risk Assessment; Risk Factors; RNA, Long Noncoding; RNA, Messenger; Running; Saccharomyces cerevisiae; Saccharomyces cerevisiae Proteins; Salinity; Salmeterol Xinafoate; Sarcoma; Seasons; Shoulder Injuries; Signal Transduction; Silicon Dioxide; Silver; Sirtuin 1; Sirtuins; Skull Fractures; Social Determinants of Health; Sodium; Sodium Fluoride; Sodium Potassium Chloride Symporter Inhibitors; Sodium-Glucose Transporter 2 Inhibitors; Soil; Soil Pollutants; Spain; Spectrophotometry; Spectroscopy, Fourier Transform Infrared; Staphylococcal Protein A; Staphylococcus aureus; Stem Cells; Stereoisomerism; Stomach Neoplasms; Streptomyces; Strontium; Structure-Activity Relationship; Students, Nursing; Substance-Related Disorders; Succinic Acid; Sulfur; Surface Properties; Survival Rate; Survivin; Symporters; T-Lymphocytes; Temozolomide; Tensile Strength; Thiazoles; Thiobacillus; Thiohydantoins; Thiourea; Thrombectomy; Time Factors; Titanium; Tobacco Mosaic Virus; Tobacco Use Disorder; Toll-Like Receptor 4; Toluene; Tomography, X-Ray Computed; TOR Serine-Threonine Kinases; Toxicity Tests, Acute; Toxicity Tests, Subacute; Transcriptional Activation; Treatment Outcome; Troponin I; Tumor Cells, Cultured; Tumor Escape; Tumor Hypoxia; Tumor Microenvironment; Tumor Necrosis Factor Inhibitors; Tumor Necrosis Factor-alpha; Tyrosine; Ubiquitin-Protein Ligases; Ubiquitination; Ultrasonic Waves; United Kingdom; United States; United States Department of Veterans Affairs; Up-Regulation; Urea; Uric Acid; Urinary Bladder Neoplasms; Urinary Bladder, Neurogenic; Urine; Urodynamics; User-Computer Interface; Vemurafenib; Verbenaceae; Veterans; Veterans Health; Viral Load; Virtual Reality; Vitiligo; Water Pollutants, Chemical; Wildfires; Wnt Signaling Pathway; Wound Healing; X-Ray Diffraction; Xenograft Model Antitumor Assays; Xylenes; Young Adult; Zinc; Zinc Oxide; Zinc Sulfate; Zoonoses

2021
Urinary lipid and protein oxidation products upon halothane, isoflurane, or sevoflurane anesthesia in humans: potential biomarkers for a subclinical nephrotoxicity.
    Biomarkers : biochemical indicators of exposure, response, and susceptibility to chemicals, 2013, Volume: 18, Issue:1

    Topics: Acetone; Aldehydes; Anesthetics, Inhalation; Biomarkers; Female; Glycosuria; Halothane; Humans; Isoflurane; Kidney; Kidney Diseases; Lipids; Male; Methyl Ethers; Oxidation-Reduction; Proteinuria; Sevoflurane; Tyrosine

2013

Other Studies

69 other study(ies) available for tyrosine and Kidney Diseases

ArticleYear
Tyrosine and Tryptophan vibrational bands as markers of kidney injury: a renocardiac syndrome induced by renal ischemia and reperfusion study.
    Scientific reports, 2021, 07-22, Volume: 11, Issue:1

    Topics: Animals; Biomarkers; Cardio-Renal Syndrome; Disease Management; Disease Susceptibility; Kidney Diseases; Male; Mice; Organ Specificity; Reperfusion Injury; Spectrum Analysis; Tryptophan; Tyrosine

2021
Protective effect of ferulic acid on cisplatin induced nephrotoxicity in rats.
    Environmental toxicology and pharmacology, 2017, Volume: 54

    Topics: Animals; Blood Urea Nitrogen; Cisplatin; Coumaric Acids; Curcumin; Heme Oxygenase (Decyclizing); Kidney; Kidney Diseases; Male; Malondialdehyde; Peroxidase; Protective Agents; Rats, Wistar; RNA, Messenger; Tyrosine

2017
Genipin attenuates cisplatin-induced nephrotoxicity by counteracting oxidative stress, inflammation, and apoptosis.
    Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 2017, Volume: 93

    Topics: Aldehydes; Animals; Antioxidants; Apoptosis; Blood Urea Nitrogen; Caspase 3; Caspase 7; Cell Line, Tumor; Cisplatin; Creatinine; Cystatin C; Cytokines; Hepatitis A Virus Cellular Receptor 1; Humans; Inflammation; Iridoids; Kidney; Kidney Diseases; Male; Mice; Mice, Inbred C57BL; Mitogen-Activated Protein Kinases; Oxidative Stress; Poly(ADP-ribose) Polymerases; Tyrosine

2017
ShcA Adaptor Protein Promotes Nephrin Endocytosis and Is Upregulated in Proteinuric Nephropathies.
    Journal of the American Society of Nephrology : JASN, 2018, Volume: 29, Issue:1

    Topics: Animals; Biotinylation; Cell Membrane; Cytosol; Endocytosis; HEK293 Cells; Humans; Kidney Diseases; Male; Membrane Proteins; Nephrosis; Phosphorylation; Podocytes; Proteinuria; Rats; Rats, Sprague-Dawley; Signal Transduction; Src Homology 2 Domain-Containing, Transforming Protein 1; Tyrosine; Up-Regulation

2018
Tyrosinemia: a report of three cases from India.
    Indian journal of gastroenterology : official journal of the Indian Society of Gastroenterology, 2013, Volume: 32, Issue:2

    Topics: alpha-Fetoproteins; Child, Preschool; Chronic Disease; Female; Hepatomegaly; Heptanoates; Humans; India; Infant; Kidney Diseases; Male; Rickets; Tyrosine; Tyrosinemias

2013
Src64B phosphorylates Dumbfounded and regulates slit diaphragm dynamics: Drosophila as a model to study nephropathies.
    Development (Cambridge, England), 2014, Volume: 141, Issue:2

    Topics: Animals; Animals, Genetically Modified; Cell Aggregation; Cell Line; Disease Models, Animal; Drosophila melanogaster; Drosophila Proteins; Enzyme Activation; Glomerular Filtration Barrier; Humans; Kidney Diseases; Membrane Proteins; Microscopy, Electron, Transmission; Muscle Proteins; Phosphorylation; Protein-Tyrosine Kinases; Proto-Oncogene Proteins; Tyrosine

2014
A comparative study on renal biopsy before and after long-term calcineurin inhibitors therapy: an insight for pathogenesis of its toxicity.
    Human pathology, 2015, Volume: 46, Issue:1

    Topics: Adolescent; Atrophy; Biomarkers; Biopsy; Calcineurin Inhibitors; Child; Child, Preschool; Early Diagnosis; Endothelial Cells; Female; Fibrosis; Humans; Hyperplasia; Immunohistochemistry; Immunosuppressive Agents; Infant; Kidney; Kidney Diseases; Kidney Tubules, Proximal; Male; Mitochondria; Nephrotic Syndrome; Nitric Oxide Synthase Type III; Oxidative Stress; Predictive Value of Tests; Time Factors; Transforming Growth Factor beta1; Treatment Outcome; Tyrosine; Up-Regulation

2015
Disruption of the cytochrome P-450 1B1 gene exacerbates renal dysfunction and damage associated with angiotensin II-induced hypertension in female mice.
    American journal of physiology. Renal physiology, 2015, May-01, Volume: 308, Issue:9

    Topics: Angiotensin II; Animals; Catalase; Cytochrome P-450 CYP1B1; Disease Models, Animal; Drinking; Estradiol; Female; Fibrosis; Genotype; Hypertension; Kidney; Kidney Diseases; Mice, Inbred C57BL; Mice, Knockout; NADPH Oxidases; Natriuresis; Oxidative Stress; Phenotype; Renin-Angiotensin System; Sex Factors; Superoxide Dismutase; Superoxides; Tyrosine; Urination

2015
50 years ago in The Journal of Pediatrics: Tyrosinemia--an inborn error of tyrosine metabolism with cirrhosis of the liver and multiple renal defects.
    The Journal of pediatrics, 2015, Volume: 166, Issue:4

    Topics: Child; History, 20th Century; Humans; Kidney Diseases; Liver Cirrhosis; Pediatrics; Periodicals as Topic; Tyrosine; Tyrosinemias

2015
Protective effects of tirofiban on ischemia/reperfusion-induced renal injury in vivo and in vitro.
    European journal of pharmacology, 2015, Aug-15, Volume: 761

    Topics: Animals; Antioxidants; Apoptosis; Biomarkers; Blood Urea Nitrogen; Cell Line; Chemotaxis, Leukocyte; Creatinine; Cytoprotection; Disease Models, Animal; Kidney; Kidney Diseases; Male; Nitric Oxide; Nitric Oxide Synthase Type II; Nitric Oxide Synthase Type III; Oxidative Stress; Rats, Sprague-Dawley; Reactive Oxygen Species; Reperfusion Injury; Tirofiban; Tyrosine

2015
Prion Protein Protects against Renal Ischemia/Reperfusion Injury.
    PloS one, 2015, Volume: 10, Issue:9

    Topics: Animals; Extracellular Signal-Regulated MAP Kinases; Heme Oxygenase-1; Kidney; Kidney Diseases; Mice; Mice, Knockout; Mitochondria; Oxidative Stress; Prions; Reperfusion Injury; Tyrosine

2015
The mechanisms associated with the development of hypertension after exposure to lead, mercury species or their mixtures differs with the metal and the mixture ratio.
    Toxicology, 2016, Jan-02, Volume: 339

    Topics: Animals; Blood Pressure; Drinking Water; Glutathione; Hypertension; Kidney Diseases; Lead; Liver; Male; Mercury; Methylmercury Compounds; Oxidative Stress; Rats; Rats, Wistar; Renin-Angiotensin System; Tyrosine

2016
Protect effect of bicyclol on cisplatin-induced nephrotoxicity in mice.
    Archives of toxicology, 2009, Volume: 83, Issue:4

    Topics: Animals; Antineoplastic Agents; Biphenyl Compounds; Cisplatin; Disease Models, Animal; Free Radical Scavengers; Glutathione; Kidney; Kidney Diseases; Male; Malondialdehyde; Mice; Mice, Inbred ICR; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Mitogen-Activated Protein Kinase Kinases; Nitric Oxide; Oxidative Stress; p38 Mitogen-Activated Protein Kinases; Tyrosine

2009
MnTMPyP, a cell-permeant SOD mimetic, reduces oxidative stress and apoptosis following renal ischemia-reperfusion.
    American journal of physiology. Renal physiology, 2009, Volume: 296, Issue:2

    Topics: Animals; Antioxidants; Apoptosis; Caspase 3; Creatinine; Gene Expression; Kidney; Kidney Diseases; Kidney Function Tests; Lipid Peroxidation; Male; Metalloporphyrins; Oxidative Stress; Rats; Rats, Sprague-Dawley; Reperfusion Injury; Superoxide Dismutase; Superoxides; Tumor Necrosis Factor-alpha; Tyrosine

2009
Differences in immunolocalization of Kim-1, RPA-1, and RPA-2 in kidneys of gentamicin-, cisplatin-, and valproic acid-treated rats: potential role of iNOS and nitrotyrosine.
    Toxicologic pathology, 2009, Volume: 37, Issue:5

    Topics: Animals; Antigens; Cell Adhesion Molecules; Cisplatin; Gentamicins; Immunohistochemistry; Kidney; Kidney Diseases; Kidney Tubules, Proximal; Male; Nitric Oxide Synthase Type II; Photomicrography; Rats; Rats, Sprague-Dawley; Statistics, Nonparametric; Tyrosine; Valproic Acid

2009
Cannabinoid-2 receptor limits inflammation, oxidative/nitrosative stress, and cell death in nephropathy.
    Free radical biology & medicine, 2010, Feb-01, Volume: 48, Issue:3

    Topics: Animals; Antineoplastic Agents; Apoptosis; Cannabinoids; Caspases; Cisplatin; In Situ Nick-End Labeling; Inflammation; Kidney Diseases; Kidney Function Tests; Lipid Peroxidation; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Oxidation-Reduction; Oxidative Stress; Peroxidase; Poly(ADP-ribose) Polymerases; Reactive Oxygen Species; Receptor, Cannabinoid, CB2; Tyrosine

2010
Poly(ADP-ribose) polymerase-1 (PARP-1) gene deficiency alleviates diabetic kidney disease.
    Biochimica et biophysica acta, 2010, Volume: 1802, Issue:11

    Topics: Albuminuria; Animals; Blood Glucose; Blotting, Western; Diabetes Mellitus, Experimental; Enzyme-Linked Immunosorbent Assay; Hypertrophy; Immunohistochemistry; Kidney; Kidney Diseases; Male; Mice; Mice, Inbred Strains; Mice, Knockout; Podocytes; Poly (ADP-Ribose) Polymerase-1; Poly(ADP-ribose) Polymerases; Transforming Growth Factor beta1; Tyrosine

2010
Plasma nitroproteome of kidney disease patients.
    Amino acids, 2011, Volume: 40, Issue:2

    Topics: Aged; Aged, 80 and over; Amino Acid Sequence; Blood Proteins; Case-Control Studies; Chronic Disease; Electrophoresis, Gel, Two-Dimensional; Female; Humans; Kidney Diseases; Male; Middle Aged; Molecular Sequence Data; Protein Processing, Post-Translational; Proteome; Tandem Mass Spectrometry; Tyrosine

2011
The nitric oxide donor molsidomine rescues cardiac function in rats with chronic kidney disease and cardiac dysfunction.
    American journal of physiology. Heart and circulatory physiology, 2010, Volume: 299, Issue:6

    Topics: Administration, Oral; Animals; Biomarkers; Cardiotonic Agents; Creatinine; Disease Models, Animal; Gene Expression Regulation; Kidney Diseases; Male; Molsidomine; Myocardial Contraction; Myocardium; Nephrectomy; Nitric Oxide; Nitric Oxide Donors; Nitroarginine; Rats; Rats, Inbred Lew; Stroke Volume; Time Factors; Tyrosine; Ventricular Dysfunction, Left; Ventricular Function, Left; Ventricular Pressure

2010
Expressions of protein oxidation markers, dityrosine and advanced oxidation protein products in Cisplatin-induced nephrotoxicity in rats.
    The Journal of veterinary medical science, 2011, Volume: 73, Issue:3

    Topics: Animals; Antineoplastic Agents; Biomarkers; Cisplatin; Gene Expression Regulation; Kidney Diseases; Oxidation-Reduction; Rats; Time Factors; Tyrosine

2011
Twelve weeks of treadmill exercise does not alter age-dependent chronic kidney disease in the Fisher 344 male rat.
    The Journal of physiology, 2011, Dec-15, Volume: 589, Issue:Pt 24

    Topics: Aging; Animals; Aorta; Chronic Disease; Hydrogen Peroxide; Kidney; Kidney Diseases; Male; NADPH Oxidases; Nitric Oxide Synthase Type I; Nitric Oxide Synthase Type III; Oxidative Stress; Physical Conditioning, Animal; Rats; Rats, Inbred F344; Superoxide Dismutase; Tyrosine

2011
A phytochemical approach to experimental metabolic syndrome-associated renal damage and oxidative stress.
    Rejuvenation research, 2012, Volume: 15, Issue:2

    Topics: 2,4-Dinitrophenol; Animals; Antioxidants; Fructose; Kidney; Kidney Diseases; Lipid Peroxidation; Male; Metabolic Syndrome; Oxidation-Reduction; Oxidative Stress; Phytotherapy; Rats; Rats, Wistar; Tyrosine

2012
Chronic treatment with tempol does not significantly ameliorate renal tissue hypoxia or disease progression in a rodent model of polycystic kidney disease.
    Clinical and experimental pharmacology & physiology, 2012, Volume: 39, Issue:11

    Topics: Animals; Arterial Pressure; Cell Hypoxia; Creatinine; Cyclic N-Oxides; Disease Progression; Glucose Transporter Type 1; Heme Oxygenase (Decyclizing); Hemodynamics; Hypertension; Hypoxia-Inducible Factor 1, alpha Subunit; Kidney; Kidney Diseases; Male; Membrane Glycoproteins; NADPH Oxidase 2; NADPH Oxidases; Oxidative Stress; Polycystic Kidney Diseases; Rats; Rats, Inbred Lew; Spin Labels; Superoxide Dismutase; Superoxide Dismutase-1; Tyrosine; Vascular Endothelial Growth Factor A

2012
Potential of sanguiin H-6 against oxidative damage in renal mitochondria and apoptosis mediated by peroxynitrite in vivo.
    Nephron, 2002, Volume: 92, Issue:1

    Topics: Animals; Blood Urea Nitrogen; Caspase 3; Caspases; Creatinine; Disease Models, Animal; DNA Fragmentation; Hydrolyzable Tannins; Ischemia; Kidney; Kidney Diseases; Lipopolysaccharides; Male; Mitochondria; Oxidative Stress; Peroxynitrous Acid; Rats; Rats, Wistar; Sanguisorba; Tannins; Tyrosine

2002
Lipoteichoic acid from Staphylococcus aureus reduces renal ischemia/reperfusion injury.
    Kidney international, 2002, Volume: 62, Issue:4

    Topics: Animals; Antioxidants; Cyclic N-Oxides; Kidney Diseases; Kidney Tubules; Lipopolysaccharides; Male; Malondialdehyde; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; P-Selectin; Peroxidase; Rats; Rats, Wistar; Reperfusion Injury; Spin Labels; Staphylococcus aureus; Teichoic Acids; Tyrosine

2002
Correlative studies of urine fluorescence and free radical indicators.
    Clinical nephrology, 2002, Volume: 58, Issue:5

    Topics: Cross-Sectional Studies; Feasibility Studies; Free Radicals; Glycation End Products, Advanced; Humans; Kidney Diseases; Reproducibility of Results; Sensitivity and Specificity; Severity of Illness Index; Spectrometry, Fluorescence; Tyrosine

2002
TEMPONE reduces renal dysfunction and injury mediated by oxidative stress of the rat kidney.
    Free radical biology & medicine, 2002, Dec-01, Volume: 33, Issue:11

    Topics: Animals; Coloring Agents; Dose-Response Relationship, Drug; Hydrogen Peroxide; Immunohistochemistry; Kidney; Kidney Diseases; Male; Mice; Nitrogen; Oxidative Stress; Poly Adenosine Diphosphate Ribose; Poly(ADP-ribose) Polymerases; Rats; Rats, Wistar; Reactive Oxygen Species; Reperfusion Injury; Tetrazolium Salts; Thiazoles; Triacetoneamine-N-Oxyl; Tyrosine; Urine

2002
Increased plasma S-nitrosothiol levels in chronic haemodialysis patients.
    Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 2003, Volume: 18, Issue:1

    Topics: Biomarkers; C-Reactive Protein; Erythrocytes; Female; Glutathione; Glutathione Peroxidase; Humans; Iron; Kidney Diseases; Kidney Failure, Chronic; Male; Middle Aged; Nitric Oxide; Reference Values; Renal Dialysis; S-Nitrosothiols; Transferrin; Tyrosine

2003
Hyperhomocysteinemia induces renal hemodynamic dysfunction: is nitric oxide involved?
    Journal of the American Society of Nephrology : JASN, 2003, Volume: 14, Issue:3

    Topics: Animals; Cyclic GMP; Homocysteine; Hyperhomocysteinemia; Kidney Diseases; Male; Nitric Oxide; Oxidative Stress; Rats; Rats, Wistar; Renal Circulation; Thiobarbituric Acid Reactive Substances; Tyrosine

2003
GW274150, a potent and highly selective inhibitor of iNOS, reduces experimental renal ischemia/reperfusion injury.
    Kidney international, 2003, Volume: 63, Issue:3

    Topics: Animals; Creatinine; Enzyme Inhibitors; Kidney; Kidney Diseases; Male; Mice; Mice, Inbred C57BL; Mice, Mutant Strains; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Peroxidase; Poly Adenosine Diphosphate Ribose; Rats; Rats, Wistar; Reperfusion Injury; Sulfides; Tyrosine; Urea

2003
HO-1 induction attenuates renal damage and oxidative stress induced by K2Cr2O7.
    Free radical biology & medicine, 2003, Jun-01, Volume: 34, Issue:11

    Topics: Animals; Blotting, Western; Caustics; Creatinine; Enzyme Induction; Heme Oxygenase (Decyclizing); Heme Oxygenase-1; Kidney; Kidney Diseases; Male; Oxidative Stress; Potassium Dichromate; Protoporphyrins; Rats; Rats, Wistar; Tin Compounds; Tyrosine

2003
FAMILIAL CIRRHOSIS OF THE LIVER, RENAL TUBULAR DEFECTS WITH RICKETS AND IMPAIRED TYROSINE METABOLISM.
    Acta paediatrica, 1964, Volume: 53

    Topics: Child; Chronic Kidney Disease-Mineral and Bone Disorder; Genetic Diseases, Inborn; Genetics; Humans; Infant; Infant, Newborn; Kidney Diseases; Kidney Tubules; Liver Cirrhosis; Metabolic Diseases; Nephrosis; Phenylpyruvic Acids; Proteins; Renal Aminoacidurias; Rickets; Spleen; Tyrosine; Vitamin D

1964
[CONGENITAL CIRRHOSIS WITH COMPLEX RENAL TUBULE DISEASE DUE TO AN ANOMALY OF TYROSINE METABOLISM].
    Revue medico-chirurgicale des maladies du foie, 1964, Volume: 39

    Topics: Amino Acid Metabolism, Inborn Errors; Carcinoma, Hepatocellular; Chronic Kidney Disease-Mineral and Bone Disorder; Genetics, Medical; Humans; Infant; Infant, Newborn; Infant, Newborn, Diseases; Kidney Diseases; Liver Cirrhosis; Liver Neoplasms; Pathology; Phenylacetates; Phenylpyruvic Acids; Renal Aminoacidurias; Renal Tubular Transport, Inborn Errors; Rickets; Tyrosine

1964
TYROSINEMIA.
    The Journal of pediatrics, 1965, Volume: 66

    Topics: Acid-Base Equilibrium; Amino Acid Metabolism, Inborn Errors; Biochemical Phenomena; Biochemistry; Blood; Child; Chronic Kidney Disease-Mineral and Bone Disorder; Drug Therapy; Fanconi Syndrome; Genetics, Medical; Humans; Infant; Infant, Newborn; Kidney Diseases; Kidney Function Tests; Kidney Tubules; Liver Cirrhosis; Liver Function Tests; Pathology; Pigmentation Disorders; Prognosis; Proteinuria; Radiography; Rickets; Thrombocytopenia; Tyrosine; Tyrosinemias; Vitamin D; Water-Electrolyte Balance

1965
S-allylmercaptocysteine scavenges hydroxyl radical and singlet oxygen in vitro and attenuates gentamicin-induced oxidative and nitrosative stress and renal damage in vivo.
    BMC clinical pharmacology, 2004, Apr-30, Volume: 4

    Topics: Aldehydes; Animals; Biomarkers; Body Weight; Carboxylic Acids; Cysteine; Dinitrophenols; Energy Intake; Free Radical Scavengers; Gentamicins; Hydroxyl Radical; Immunohistochemistry; Kidney Cortex; Kidney Diseases; Kidney Glomerulus; Kidney Tubules, Proximal; Male; Oxidation-Reduction; Oxidative Stress; Proteins; Rats; Rats, Wistar; Reactive Oxygen Species; Tyrosine; Urine

2004
Peroxynitrite decomposition catalyst ameliorates renal damage and protein nitration in cisplatin-induced nephrotoxicity in rats.
    BMC pharmacology, 2004, Sep-30, Volume: 4

    Topics: Animals; Body Weight; Catalysis; Cisplatin; Glomerular Mesangium; Kidney Diseases; Kidney Tubules; Male; Metalloporphyrins; Peroxynitrous Acid; Rats; Rats, Wistar; Reactive Nitrogen Species; Tyrosine; Urine

2004
Selenium-binding protein-1 in smooth muscle cells is downregulated in a rhesus monkey model of chronic allograft nephropathy.
    American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons, 2005, Volume: 5, Issue:1

    Topics: Actins; Animals; Carrier Proteins; Cell Line; Coronary Vessels; Detergents; Disease Models, Animal; Down-Regulation; Electrophoresis, Gel, Two-Dimensional; Female; Humans; Immunohistochemistry; Immunosuppressive Agents; Kidney; Kidney Diseases; Macaca mulatta; Mass Spectrometry; Muscle, Smooth; Nephritis; Phosphoproteins; Phosphorylation; Reverse Transcriptase Polymerase Chain Reaction; Selenium-Binding Proteins; Transforming Growth Factor beta; Tyrosine; Uterus

2005
In vivo genetic selection of renal proximal tubules.
    Molecular therapy : the journal of the American Society of Gene Therapy, 2006, Volume: 13, Issue:1

    Topics: Acute Disease; Animals; Bone Marrow Transplantation; Cell Differentiation; Cell Fusion; Chronic Disease; Disease Models, Animal; Homogentisate 1,2-Dioxygenase; Homogentisic Acid; Hydrolases; Kidney Diseases; Kidney Tubules, Proximal; Male; Mice; Mice, Knockout; Necrosis; Regeneration; Tyrosine; Urothelium

2006
Nitisinone in the treatment of hereditary tyrosinaemia type 1.
    Drugs, 2006, Volume: 66, Issue:6

    Topics: Carcinoma, Hepatocellular; Cyclohexanones; Enzyme Inhibitors; Humans; Kidney Diseases; Liver Diseases; Liver Failure; Liver Neoplasms; Liver Transplantation; Monitoring, Physiologic; Nitrobenzoates; Tyrosine; Tyrosinemias

2006
Genetic suppression of HO-1 exacerbates renal damage: reversed by an increase in the antiapoptotic signaling pathway.
    American journal of physiology. Renal physiology, 2007, Volume: 292, Issue:1

    Topics: Animals; Apoptosis; Blood Pressure; Blotting, Western; Cell Nucleus; Creatine; Cyclooxygenase 2; DNA Fragmentation; Gene Expression Regulation, Enzymologic; Genetic Vectors; Heme Oxygenase (Decyclizing); Heme Oxygenase-1; Hypertension, Renovascular; Kidney Diseases; Protoporphyrins; Rats; Rats, Sprague-Dawley; Renal Artery; Retroviridae; RNA, Antisense; Signal Transduction; Tyrosine

2007
Sex differences in major bleeding with glycoprotein IIb/IIIa inhibitors: results from the CRUSADE (Can Rapid risk stratification of Unstable angina patients Suppress ADverse outcomes with Early implementation of the ACC/AHA guidelines) initiative.
    Circulation, 2006, Sep-26, Volume: 114, Issue:13

    Topics: Acute Disease; Adult; Angina, Unstable; Blood Transfusion; Cerebral Hemorrhage; Creatinine; Disease Susceptibility; Dose-Response Relationship, Drug; Eptifibatide; Glomerular Filtration Rate; Hemorrhage; Hemorrhagic Disorders; Humans; Kidney Diseases; Myocardial Infarction; Peptides; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Practice Guidelines as Topic; Registries; Sex Characteristics; Tirofiban; Tyrosine

2006
Role of peroxynitrite on cytoskeleton alterations and apoptosis in renal ischemia-reperfusion.
    American journal of physiology. Renal physiology, 2007, Volume: 292, Issue:6

    Topics: Animals; Apoptosis; Blood Pressure; Blood Urea Nitrogen; Blotting, Western; Caspase 3; Cytoskeleton; In Situ Nick-End Labeling; Kidney Diseases; Kidney Function Tests; Male; Microscopy, Confocal; Peroxynitrous Acid; Rats; Rats, Wistar; Reperfusion Injury; Tyrosine

2007
Isohumulones derived from hops ameliorate renal injury via an anti-oxidative effect in Dahl salt-sensitive rats.
    Hypertension research : official journal of the Japanese Society of Hypertension, 2007, Volume: 30, Issue:2

    Topics: Animals; Antioxidants; Blood Pressure; Blotting, Western; Cyclopentanes; Humulus; Hypertension; Kidney Diseases; Nitrates; Nitric Oxide; Nitric Oxide Synthase; Nitrites; Oxidative Stress; Proteinuria; Rats; Rats, Inbred Dahl; Reactive Oxygen Species; Sodium Chloride; Tyrosine

2007
Pioglitazone ameliorates endothelial dysfunction in obese rats with nephropathy.
    Biochemical and biophysical research communications, 2007, Oct-05, Volume: 361, Issue:4

    Topics: Animals; Endothelium, Vascular; Kidney Diseases; Kidney Glomerulus; Male; Metabolic Syndrome; NADPH Oxidases; Obesity; Pioglitazone; Polymerase Chain Reaction; Rats; Rats, Zucker; RNA, Messenger; Thiazolidinediones; Tyrosine; Vasodilation

2007
Effects of resveratrol on glycerol-induced renal injury.
    Life sciences, 2007, Aug-02, Volume: 81, Issue:8

    Topics: Animals; Antioxidants; Blotting, Western; Glycerol; Heme Oxygenase-1; Immunohistochemistry; Kidney Cortex; Kidney Diseases; Kidney Function Tests; Lipid Peroxidation; Lymphocytes; Macrophages; Male; Malondialdehyde; NF-kappa B; Rats; Rats, Wistar; Resveratrol; Stilbenes; Tyrosine

2007
Selective iNOS inhibition reduces renal damage induced by cisplatin.
    Toxicology letters, 2008, Jan-04, Volume: 176, Issue:1

    Topics: Aldehydes; Amidines; Animals; Antineoplastic Agents; Benzylamines; Cisplatin; Disease Models, Animal; Enzyme Inhibitors; Gene Expression Regulation, Enzymologic; Kidney; Kidney Diseases; Male; Malondialdehyde; Nitric Oxide; Nitric Oxide Synthase Type II; Oxidative Stress; Rats; Rats, Wistar; RNA, Messenger; Tyrosine

2008
Dietary treatment of tyrosinosis.
    American journal of diseases of children (1960), 1967, Volume: 113, Issue:1

    Topics: Amino Acid Metabolism, Inborn Errors; Child, Preschool; Diet Therapy; Female; Growth; Humans; Infant; Kidney Diseases; Kidney Tubules; Liver Cirrhosis; Methionine; Mixed Function Oxygenases; Phenylalanine; Phosphorus; Rickets; Tyrosine

1967
Dietary treatment in tyrosinemia (tyrosinosis). With a note on the possible recognition of the carrier state.
    American journal of diseases of children (1960), 1967, Volume: 113, Issue:1

    Topics: Amino Acid Metabolism, Inborn Errors; Carrier State; Child; Child, Preschool; Diet Therapy; Female; Growth; Humans; Kidney Diseases; Kidney Tubules; Male; Mixed Function Oxygenases; Phenylacetates; Phenylalanine; Seizures; Tyrosine

1967
Toxicologic studies with alpha-methyltyrosine, an inhibitor of tyrosine hydroxylase.
    The Journal of pharmacology and experimental therapeutics, 1967, Volume: 155, Issue:3

    Topics: Animals; Behavior, Animal; Blood Glucose; Blood Urea Nitrogen; Body Temperature; Body Weight; Brain Chemistry; Catecholamines; Enzymes; Female; Glycosuria; Hematuria; Hypothermia, Induced; Kidney; Kidney Diseases; Methyltyrosines; Organ Size; Polyuria; Proteinuria; Rats; Tyrosine; Water

1967
On the renal tubular damage in hereditary tyrosinemia and on the formation of succinylacetoacetate and succinylacetone.
    Acta paediatrica Scandinavica, 1981, Volume: 70, Issue:3

    Topics: Acetoacetates; Amino Acid Metabolism, Inborn Errors; Aminolevulinic Acid; Child; Heptanoates; Homogentisic Acid; Humans; Infant; Keto Acids; Kidney Diseases; Kidney Tubules; Male; Phenylalanine; Proteinuria; Tyrosine

1981
The nephropathy of type I tyrosinemia after liver transplantation.
    Pediatric research, 1995, Volume: 37, Issue:5

    Topics: Amino Acid Metabolism, Inborn Errors; Child, Preschool; Follow-Up Studies; Humans; Infant; Kidney; Kidney Diseases; Liver; Liver Transplantation; Tyrosine

1995
Image interpretation session. Tyrosinemia with hepatic and renal involvement and possible associated hepatocellular carcinoma.
    Radiographics : a review publication of the Radiological Society of North America, Inc, 1995, Volume: 15, Issue:1

    Topics: Amino Acid Metabolism, Inborn Errors; Carcinoma, Hepatocellular; Female; Humans; Infant; Kidney Diseases; Liver; Liver Diseases; Liver Neoplasms; Tyrosine

1995
Treatment of two children with hereditary tyrosinaemia type I and long-standing renal disease with a 4-hydroxyphenylpyruvate dioxygenase inhibitor (NTBC).
    Journal of inherited metabolic disease, 1996, Volume: 19, Issue:2

    Topics: 4-Hydroxyphenylpyruvate Dioxygenase; Amino Acid Metabolism, Inborn Errors; Child; Cyclohexanones; Enzyme Inhibitors; Female; Humans; Kidney Diseases; Male; Nitrobenzoates; Osteoporosis; Phosphates; Reference Values; Tyrosine; Uric Acid

1996
Nephropathy of tyrosinemia and its long-term outlook.
    Journal of pediatric gastroenterology and nutrition, 1997, Volume: 24, Issue:1

    Topics: Amino Acid Metabolism, Inborn Errors; Child, Preschool; Humans; Infant; Kidney Diseases; Liver Transplantation; Tyrosine

1997
Internalization of Escherichia coli by human renal epithelial cells is associated with tyrosine phosphorylation of specific host cell proteins.
    Infection and immunity, 1997, Volume: 65, Issue:7

    Topics: Cells, Cultured; Cytoskeletal Proteins; Epithelium; Escherichia coli; Escherichia coli Infections; Humans; Kidney; Kidney Diseases; Phosphorylation; Protein-Tyrosine Kinases; Pyelonephritis; Signal Transduction; Tyrosine

1997
Increased potency and decreased elimination of lamifiban, a GPIIb-IIIa antagonist, in patients with severe renal dysfunction.
    Thrombosis and haemostasis, 1998, Volume: 79, Issue:6

    Topics: Acetates; Adenosine Diphosphate; Adult; Aged; Bleeding Time; Creatinine; Female; Half-Life; Hematoma; Humans; Kidney Diseases; Kidney Function Tests; Male; Metabolic Clearance Rate; Middle Aged; Oligopeptides; Platelet Activation; Platelet Aggregation Inhibitors; Platelet Count; Platelet Glycoprotein GPIIb-IIIa Complex; Thrombosis; Tyrosine

1998
Inhibition of nitric oxide synthase ameliorates cellular injury in sickle cell mouse kidneys.
    Kidney international, 2000, Volume: 58, Issue:1

    Topics: Alanine Transaminase; Anemia, Sickle Cell; Animals; Apoptosis; Aspartate Aminotransferases; Blotting, Western; Cell Hypoxia; DNA Fragmentation; Electrophoresis, Agar Gel; Enzyme Inhibitors; Guanidines; Immunohistochemistry; In Situ Nick-End Labeling; Kidney Diseases; Kidney Tubules; Mice; Mice, Inbred C57BL; Mice, Transgenic; Nitrates; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Nitric Oxide Synthase Type III; Poly(ADP-ribose) Polymerases; Tyrosine

2000
New treatment for tyrosinaemia.
    Lancet (London, England), 1992, Oct-03, Volume: 340, Issue:8823

    Topics: 4-Hydroxyphenylpyruvate Dioxygenase; Amino Acid Metabolism, Inborn Errors; Cyclohexanones; Humans; Infant; Kidney Diseases; Liver Diseases; Nitrobenzoates; Tyrosine

1992
Type I hereditary tyrosinaemia: presentation of 11 cases.
    Journal of inherited metabolic disease, 1991, Volume: 14, Issue:5

    Topics: Amino Acid Metabolism, Inborn Errors; Amino Acids; Carcinoma, Hepatocellular; Child; Child, Preschool; Female; Fibroblasts; Humans; Hydrolases; Infant; Kidney Diseases; Liver Cirrhosis; Liver Neoplasms; Male; Rickets; Tyrosine

1991
Liver transplantation in a 23-year-old tyrosinaemia patient: effects on the renal tubular dysfunction.
    Journal of inherited metabolic disease, 1986, Volume: 9, Issue:2

    Topics: Adult; Amino Acid Metabolism, Inborn Errors; Amino Acids; beta 2-Microglobulin; Female; Glycosuria; Heptanoates; Humans; Kidney Diseases; Kidney Tubules; Liver Diseases; Liver Transplantation; Phosphates; Tyrosine

1986
[Contribution to differential diagnosis of crystalline precipitates in renal tissue].
    Mikroskopie, 1972, Volume: 27, Issue:7

    Topics: Autopsy; Calcium; Crystallography; Cystine; Diagnosis, Differential; Histological Techniques; Humans; Kidney; Kidney Diseases; Oxalates; Solvents; Tyrosine; Uric Acid

1972
Studies on the metabolism of phenylalanine and tyrosine in patients with renal disease.
    Clinica chimica acta; international journal of clinical chemistry, 1973, Sep-28, Volume: 48, Issue:1

    Topics: Adult; Amino Acids; Analysis of Variance; Chromatography, Paper; Female; Humans; Kidney Diseases; Kidney Failure, Chronic; Kidney Transplantation; Liver Function Tests; Male; Middle Aged; Phenylalanine; Renal Dialysis; Time Factors; Tyrosine

1973
Hereditary tyrosinemia with hyperplasia and hypertrophy of juxtaglomerular apparatus.
    American journal of clinical pathology, 1974, Volume: 61, Issue:3

    Topics: Autopsy; Female; Galactosemias; Humans; Hyperplasia; Hypertrophy; Infant; Juxtaglomerular Apparatus; Kidney; Kidney Diseases; Liver; Metabolism, Inborn Errors; Pancreas; Phenylpyruvic Acids; Tyrosine

1974
Quantitative changes in plasma amino acids in patients with renal disease.
    Clinica chimica acta; international journal of clinical chemistry, 1972, Volume: 38, Issue:2

    Topics: Adult; Amino Acids; Chromatography, Paper; Fasting; Female; Humans; Kidney Diseases; Male; Mathematics; Middle Aged; Phenylalanine; Renal Dialysis; Tyrosine; Urea

1972
Tyrosinosis: a patient without liver or renal disease.
    Pediatrics, 1971, Volume: 48, Issue:3

    Topics: Amino Acid Metabolism, Inborn Errors; Child; Chromatography, Ion Exchange; Chromatography, Paper; Humans; Intellectual Disability; Kidney Diseases; Lactates; Liver; Liver Diseases; Male; Mixed Function Oxygenases; Phenylacetates; Phenylpyruvic Acids; Tyrosine

1971
[Four uncommon pediatric conditions associated with bilateral nephromegaly].
    Annales de radiologie, 1969, Volume: 12, Issue:3

    Topics: Abnormalities, Multiple; Glycogen Storage Disease Type I; Humans; Hyperplasia; Infant; Infant, Newborn; Kidney Diseases; Lipodystrophy; Male; Tyrosine

1969
[Clinical study on the cardiac tolerance and biological action of a lyophilized thyroid extract administered orally. Apropos of 30 cases].
    Lille medical : journal de la Faculte de medecine et de pharmacie de l'Universite de Lille, 1968, Volume: 13, Issue:3

    Topics: Administration, Oral; Adolescent; Adult; Aged; Female; Heart; Humans; Hypercholesterolemia; Hypertension; Kidney Diseases; Liver Cirrhosis; Male; Middle Aged; Monoiodotyrosine; Obesity Hypoventilation Syndrome; Porphyrias; Thyroid Hormones; Tyrosine

1968
[Experimental studies in a case of tyrosinosis. New pathogenic hypothesis].
    Revue francaise d'etudes cliniques et biologiques, 1969, Volume: 14, Issue:1

    Topics: Adult; Amino Acids; Animals; Blood Glucose; Carbon Dioxide; Chromatography; Depression, Chemical; Dietary Carbohydrates; Electrophoresis; Enzyme Induction; Female; Glycosuria; Humans; Hydrocortisone; Kidney Diseases; Kidney Tubules; Liver; Male; Metabolic Diseases; Phenols; Pregnancy; Pyridoxal Phosphate; Pyridoxine; Pyruvate Oxidase; Rats; Stimulation, Chemical; Time Factors; Transaminases; Tyrosine; Water

1969
Tyrosinosis. A study of 6 cases.
    Archives of disease in childhood, 1966, Volume: 41, Issue:217

    Topics: Amino Acid Metabolism, Inborn Errors; Blood; Chronic Kidney Disease-Mineral and Bone Disorder; Diet; Female; Humans; Infant; Kidney Diseases; Liver Cirrhosis; Male; Phenylpyruvic Acids; Radiography; Tyrosine; Urine

1966